Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| AOTFIRG23KRINGLE | Other Grant/Funding Number | American Occupational Therapy Foundation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| American Occupational Therapy Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
The goal of this intervention study is to test whether a behavioral program that involves people with stroke and their caregivers is acceptable, safe, and can promote physically active lifestyles using enjoyable activities. Participant duos (person with stroke and their caregiver) will be asked to complete assessments at 2 timepoints, wear an activity tracker, participate in 12 sessions with an occupational therapist, and complete an interview.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| duoABLE | Experimental | Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| duoABLE | Behavioral | Stroke participant-caregiver duos (dyads) will meet with an occupational therapist 12 times (2x/week for 6 weeks, approximately 30 minutes/session) to apply activity monitoring, activity scheduling, collaborative problem solving, self-assessment, and social interdependence to self-selected activities that aim to increase both dyad members' physical activity levels |
| Measure | Description | Time Frame |
|---|---|---|
| Participant satisfaction | Measured using the Client Satisfaction Questionnaire-8 (CSQ-8) | Score at week 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in activity restrictions | Proportion of activities retained assessed at baseline and 8-weeks by the Activity Card Sort 3 | Baseline to 8 weeks |
| Change in sedentary minutes per day | Minutes of sedentary time per day, measured using the activPAL micro4 (mean minutes per day determined by 7-day wear protocol) at baseline and week 8. |
Not provided
Inclusion Criteria (Stroke Participants):
Inclusion Criteria (Caregiver Participants):
Exclusion Criteria (Stroke Participants):
Exclusion Criteria (Caregiver Participants):
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Emily A Kringle, PhD, OTR/L | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| School of Kinesiology, University of Minnesota | Minneapolis | Minnesota | 55455 | United States |
There are no current plans to share data with other investigators. Upon the completion of the study, a de-identified dataset that includes questionnaire data, raw and processed activPAL data, and transcribed interview data will be created and stored in the DWELL Laboratory at the University of Minnesota. The PI will consider individual requests for data sharing and provide only the necessary de-identified data upon reasonable request, under a University of Minnesota data use agreement.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D000083242 | Ischemic Stroke |
| D000083302 | Hemorrhagic Stroke |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline to 8 weeks |
| Change in daily step count | Count of steps per day, measured using the activPAL micro4 (mean daily step count determined by 7-day wear protocol) at baseline and week 8. | Baseline to 8 weeks |
| Change in Health-related quality of life | Change in score on the EuroQoL-5 Dimensions-5 Levels (EQ-5D-5L) measured at baseline and week 8 | Baseline to 8 weeks |
| Adverse event count | Total count of adverse events over the course of the study based on an adverse events questionnaire completed at 8 weeks | Count of adverse events at week 8 |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001519 | Behavior |